Adjunct extended-release valproate semisodium in late life schizophreniaSAJATOVIC, Martha; COCONCEA, Nicoleta; IGNACIO, Rosalinda V et al.International journal of geriatric psychiatry. 2008, Vol 23, Num 2, pp 142-147, issn 0885-6230, 6 p.Article

Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbitalBRIZENDINE, Christina E; NAIK, Paras J.American journal of health-system pharmacy. 2013, Vol 70, Num 6, pp 507-510, issn 1079-2082, 4 p.Article

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute maniaBOWDEN, Charles L; SWANN, Alan C; CALABRESE, Joseph R et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 10, pp 1501-1510, issn 0160-6689, 10 p.Article

Direct observation of 3-keto-valproate in urine by 2D-NMR spectroscopyMESHITSUKA, Shunsuke; KOEDA, Tatsuya; MURO, Hideki et al.Clinica chimica acta. 2003, Vol 334, Num 1-2, pp 145-151, issn 0009-8981, 7 p.Article

Acidose et hyperlactatémie lors des intoxications aiguës par le valproate de sodium = Acidosis and hyperlactatemia in acute sodium valproate intoxicationDUMOULIN, A; LAPOSTOLLE, F; ADNET, F et al.La Presse médicale (1983). 1997, Vol 26, Num 12, pp 555-557, issn 0755-4982Article

Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderlyPORSTEINSSON, Anton P.Drugs & aging. 2006, Vol 23, Num 11, pp 877-886, issn 1170-229X, 10 p.Article

Prevention of postpartum episodes in women with bipolar disorderWISNER, Katherine L; HANUSA, Barbara H; PEINDL, Kathleen S et al.Biological psychiatry (1969). 2004, Vol 56, Num 8, pp 592-596, issn 0006-3223, 5 p.Article

Cheveux crépus acquis induits par le valproate de sodium = Sodium valproate-induced kinky hair syndromeCANEPPELE, S; MAZEREEUW-HAUTIER, J; BONAFE, J.-L et al.Annales de dermatologie et de vénéréologie. 2001, Vol 128, Num 2, pp 134-135, issn 0151-9638Article

Divalproex sodium for impulsive aggressive behavior in patients with personality disorderKAVOUSSI, R. J; COCCARO, E. F.The Journal of clinical psychiatry. 1998, Vol 59, Num 12, pp 676-680, issn 0160-6689Article

Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer DiseaseTARIOT, Pierre N; SCHNEIDER, Lon S; PORSTEINSSON, Anton et al.Archives of general psychiatry. 2011, Vol 68, Num 8, pp 853-861, issn 0003-990X, 9 p.Article

Divalproex extended-release in acute bipolar II depressionWANG, P. W; NOWAKOWSKA, C; CHANDLER, R. A et al.Journal of affective disorders. 2010, Vol 124, Num 1-2, pp 170-173, issn 0165-0327, 4 p.Article

Extended-release divalproex in child and adolescent outpatients with epilepsyKERNITSKY, Lydia; O'HARA, Kathryn A; PING JIANG et al.Epilepsia (Copenhagen). 2005, Vol 46, Num 3, pp 440-443, issn 0013-9580, 4 p.Article

Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placeboBOWDEN, Charles L; COLLINS, Michelle A; MCELROY, Susan L et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 10, pp 1932-1939, issn 0893-133X, 8 p.Article

CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithiumGRIMES, Carol A; JOPE, Richard S.Journal of neurochemistry. 2001, Vol 78, Num 6, pp 1219-1232, issn 0022-3042Article

Treatment of charles Bonnet syndrome with valproateHORI, H; TERAO, T; SHIRAISHI, Y et al.International clinical psychopharmacology. 2000, Vol 15, Num 2, pp 117-119, issn 0268-1315Article

Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 2. Mutual compensation of influence variablesTHIES, R; KLEINEBUDDE, P.European journal of pharmaceutical sciences. 2000, Vol 10, Num 2, pp 103-110, issn 0928-0987Article

Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability : a retrospective reviewRUEDRICH, S; SWALES, T. P; FOSSACECA, C et al.JIDR. Journal of intellectual disability research (Print). 1999, Vol 43, Num 2, pp 105-111, issn 0964-2633Article

Treatment of aggression in patients with bipolar disorderSWANN, A. C.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 15, pp 25-28Conference Paper

An open study of lamotrigine in refractory bipolar depressionKUSUMAKAR, V; YATHAM, L. N.Psychiatry research. 1997, Vol 72, Num 2, pp 145-148, issn 0165-1781Article

Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum DisordersHOLLANDER, Eric; CHAPLIN, William; SOORYA, Latha et al.Neuropsychopharmacology (New York, NY). 2010, Vol 35, Num 4, pp 990-998, issn 0893-133X, 9 p.Article

Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder : Childhood and adolescent mental healthFINDLING, Robert L; FRAZIER, Thomas W; YOUNGSTROM, Eric A et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 5, pp 781-788, issn 0160-6689, 8 p.Article

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorderHOLLANDER, Eric; SWANN, Alan C; COCCARO, Emil F et al.The American journal of psychiatry. 2005, Vol 162, Num 3, pp 621-624, issn 0002-953X, 4 p.Article

An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuseGOLDBERG, Joseph F; CLOITRE, Marylene; WHITESIDE, Joyce E et al.Current therapeutic research. 2003, Vol 64, Num 1, pp 45-54, issn 0011-393X, 10 p.Article

Maintenance efficacy of divalproex in the prevention of bipolar depressionGYULAI, Laszlo; BOWDEN, Charles L; NEMEROFF, Charles B et al.Neuropsychopharmacology (New York, NY). 2003, Vol 28, Num 7, pp 1374-1382, issn 0893-133X, 9 p.Article

Intravenous valproate sodium in the treatment of daily headacheSCHWARTZ, Tamara H; KARPITSKIY, Vladimir V; SOHN, Richard S et al.Headache. 2002, Vol 42, Num 6, pp 519-522, issn 0017-8748Article